SEC Form 4 · accession 0001144204-15-001911
CV Sciences, Inc. · CVSI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Michael Mona III
Officer — Vice President of Operations
Period of report
Oct 1, 2014
Accepted (ET)
Jan 12, 2015 · 9:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001510964
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 1, 2014 | P | 250,000 | $2.82 | A | 2,500,000 | D | |
| Common StockF2 | Jan 1, 2015 | P | 250,000 | $2.36 | A | 1,750,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The consideration paid for the shares was services previously provided to the Issuer by Mr. Mona, valued at $705,000, as of October 1, 2014.
- F2Excludes 1,000,000 shares previously owned indirectly by Mr. Mona as co-trustee of the Roche-Denis Trust ("Trust"). As of November 19, 2014, Mr. Mona was no longer the co-trustee or beneficiary of the Trust.